AAV Vectors Vaccines Against Infectious Diseases

Area of Science:

• Gene Therapy
• Immunology
• Vaccinology

Background:

• Adeno-associated virus (AAV) vectors are recognized for efficient in vivo gene transfer and sustained transgene expression.
• Historically, AAVs were considered low immunogenic compared to other viral vectors like adenoviruses.
• The potential of AAV vectors for vaccination was largely unexplored until the early 2000s.

Purpose of the Study:

• To review studies evaluating adeno-associated virus (AAV) vectors for vaccination against infectious agents.
• To discuss the advantages and drawbacks of using AAV vectors in vaccine development.
• To explore the immunological properties of AAVs for potential immunotherapy applications.

Main Methods:

• Literature review of studies on AAV vectors for vaccination.
• Analysis of data on immune responses induced by AAV vectors.
• Evaluation of AAV vector applications in active and passive immunotherapy.

Main Results:

• AAV vectors demonstrate potential for inducing efficient and sustained antibody responses.
• Studies suggest AAVs have unique immunological features suitable for vaccine development.
• Emerging research highlights AAVs' potential in both active and passive immunotherapy.

Conclusions:

• AAV vectors possess advantageous features for developing vaccines against infectious diseases.
• Further research into AAV's immunological properties can define future applications in immunotherapy.
• AAV vectors represent a versatile tool for advancing vaccine technology.